Crossmark

Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 “QUAD shot” regimen for incurable head and neck cancer

Crossref DOI link: https://doi.org/10.1186/s13014-020-01548-w

Published Online: 2020-05-27

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Toya, Ryo https://orcid.org/0000-0001-9764-5718
Saito, Tetsuo

Yamaguchi, Kohsei

Matsuyama, Tomohiko

Watakabe, Takahiro

Matsumoto, Tadashi

Yoshida, Ryoji

Hirosue, Akiyuki

Murakami, Daizo

Orita, Yorihisa

Nakayama, Hideki

Oya, Natsuo
License Information

Text and Data Mining valid from 2020-05-27

Version of Record valid from 2020-05-27
More Information

Article History

Received: 6 April 2020

Accepted: 22 April 2020

First Online: 27 May 2020

Ethics approval and consent to participate

: This study received the full approval from the Institutional Research Ethics Board at Kumamoto University Hospital (No. 1830). The requirement for individual participant consent was waived by the research ethics board.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below